【発明の名称】線維芽細胞増殖因子の抗イディオタイプ抗体及びそれらの薬剤としての使用 - CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS

Title:

【発明の名称】線維芽細胞増殖因子の抗イディオタイプ抗体及びそれらの薬剤としての使用

Document Type and Number:

Japanese Patent JP2003504379

Kind Code:

A

Abstract:

The invention concerns the use of anti-idiotypic antibodies of the fibroblast growth factor (1) and/or anti-idiotypic antibodies of the fibroblastic growth factor (2), for preparing a medicine for treating pathologies involving endothelial cells implied in an angiogenic process, either for inhibiting angiogenesis, or for promoting angiogenesis, without affecting the quiescent endothelial cells, or for preparing a diagnostic product for pathologies involving endothelial cells implied in an angiogenic process.

More Like This:

WO/2021/119234	GLYCOSYLATED ANTIBODIES AGAINST INSULIN-LIKE GROWTH FACTOR I RECEPTOR AND USES THEREOF
JP2019530642	Fusion protein of human protein fragments for making higher multimerized immunoglobulin FC compositions with improved Fc receptor binding
WO/2021/106978	PHARMACEUTICAL COMPOSITION

Inventors:

Plouet, Jean
Juan Renault, Jacqueline
Thierry, Jean-Paul
Savanier, pierre
Malvaux, Bernard Andre
Soldero, Sylvie

Application Number:

JP2001509769A

Publication Date:

February 04, 2003

Filing Date:

July 06, 2000

Export Citation:

Click for automatic bibliography generation Help

Assignee:

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS

International Classes:

A61K39/395; A61K47/48; A61P9/00; A61P9/10; A61P35/00; A61P37/06; C07K16/42; C12P21/08; A61K38/00; (IPC1-7): A61K39/395; A61P9/00; A61P9/10; A61P35/00; A61P37/06; C07K16/42; C12P21/08

Attorney, Agent or Firm:

Hajime Tsukuni (1 person outside)

Previous Patent: 顆粒球コロニー刺激因子の精製方法

Next Patent: 農薬組成物及び界面活性剤化合物